Literature DB >> 27036677

Editorial Comment.

Gregory B Auffenberg1, Khurshid R Ghani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27036677      PMCID： PMC4880992          DOI： 10.1016/j.urology.2015.11.047

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  8 in total

1.  Choosing wisely: helping physicians and patients make smart decisions about their care.

Authors:  Christine K Cassel; James A Guest
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

Review 2.  The emerging threat of multidrug-resistant Gram-negative bacteria in urology.

Authors:  Hosam M Zowawi; Patrick N A Harris; Matthew J Roberts; Paul A Tambyah; Mark A Schembri; M Diletta Pezzani; Deborah A Williamson; David L Paterson
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

3.  A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.

Authors:  Paul R Womble; Susan M Linsell; Yuqing Gao; Zaojun Ye; James E Montie; Tejal N Gandhi; Brian R Lane; Frank N Burks; David C Miller
Journal:  J Urol       Date:  2015-04-17       Impact factor: 7.450

Review 4.  Safety issues and drug-drug interactions with commonly used quinolones.

Authors:  Antonios Douros; Katja Grabowski; Ralf Stahlmann
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-11-26       Impact factor: 4.481

5.  Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.

Authors:  Anthony J Schaeffer; Shu-Chen Wu; Alan M Tennenberg; James B Kahn
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

6.  False-positive screening results in the European randomized study of screening for prostate cancer.

Authors:  Tuomas P Kilpeläinen; Teuvo L J Tammela; Monique Roobol; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Sue Moss; Liisa Määttänen; Anssi Auvinen
Journal:  Eur J Cancer       Date:  2011-07-23       Impact factor: 9.162

7.  Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.

Authors:  Scott E Eggener; Michael C Large; Glenn S Gerber; Joseph Pettus; Ofer Yossepowitch; Norm D Smith; Shilajit Kundu; Rangesh Kunnavakkam; Kevin Zorn; Jay D Raman
Journal:  BJU Int       Date:  2013-07-26       Impact factor: 5.588

8.  The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mL.

Authors:  Gokhan Toktas; Murat Demiray; Erkan Erkan; Ramazan Kocaaslan; Ugur Yucetas; Suleyman Erdinc Unluer
Journal:  J Endourol       Date:  2013-08       Impact factor: 2.942
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.